Search

everythinglearnresearchcommunity

for

Search:↓

Zinc is effective for treating various skin conditions, including warts and acne.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Spironolactone helps reduce pain and lesions in hidradenitis suppurativa patients, and lower doses are also effective.

Scientists have created a new hair loss treatment using ultrasound to deliver gene-editing particles, which resulted in up to 90% hair regrowth in mice.

Injecting a special gel with human protein particles can help hair grow.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

South Korean women with hair loss have lower hair density and thickness compared to healthy women.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Mesotherapy shows promise for cellulite and facial rejuvenation but has mixed results for body sculpting and hair loss, with more research needed for safety and effectiveness.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Herbal compounds like ricinoleic acid, quercetin-3-O-rutinoside, and hinokiflavone may be safe and effective for treating hair loss.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Early hair loss may indicate prostate issues.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.